Chelsea Counsel CO Abbott Laboratories Transaction History

Chelsea Counsel CO

$173 Million
Q1 2024

A detailed history of Chelsea Counsel CO transactions in Abbott Laboratories stock. As of the latest transaction made, Chelsea Counsel CO holds 21,786 shares of ABT stock, worth $2.53 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

21,786

Previous 22,054 1.22%

Holding current value

$2.53 Million

Previous $2.43 Million 2.02%

% of portfolio

1.43%

Previous 1.31%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 14, 2024	SELL	$109.52 - $120.96 $29,351 - $32,417	-268 Reduced 1.22%	21,786 $2.48 Million
Q4 2023 Feb 21, 2024	SELL	$90.19 - $110.4 $66,830 - $81,806	-741 Reduced 3.25%	22,054 $2.43 Million
Q3 2023 Nov 22, 2023	SELL	$95.53 - $114.62 $26,270 - $31,520	-275 Reduced 1.19%	22,795 $2.21 Million
Q2 2023 Nov 22, 2023	SELL	$100.78 - $112.29 $806 - $898	-8 Reduced 0.03%	23,070 $2.52 Million
Q1 2023 May 19, 2023	SELL	$96.86 - $114.01 $72,160 - $84,937	-745 Reduced 3.13%	23,078 $2.34 Million
Q4 2022 Feb 23, 2023	SELL	$95.06 - $111.52 $99,813 - $117,096	-1,050 Reduced 4.22%	23,823 $2.62 Million
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $86,116 - $99,706	-890 Reduced 3.45%	24,873 $2.41 Million
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $33,683 - $40,712	-330 Reduced 1.26%	25,763 $2.8 Million
Q1 2022 May 24, 2022	SELL	$114.02 - $139.04 $12,314 - $15,016	-108 Reduced 0.41%	26,093 $3.09 Million
Q4 2021 May 23, 2022	SELL	$115.53 - $141.46 $103,514 - $126,748	-896 Reduced 3.31%	26,201 $3.69 Million
Q3 2021 Feb 10, 2022	BUY	$116.66 - $129.06 $86,911 - $96,149	745 Added 2.83%	27,097 $3.2 Million
Q2 2021 Feb 10, 2022	SELL	$105.79 - $124.53 $6,347 - $7,471	-60 Reduced 0.23%	26,352 $3.06 Million
Q1 2021 Feb 10, 2022	SELL	$108.84 - $128.23 $21,768 - $25,645	-200 Reduced 0.75%	26,412 $3.17 Million
Q4 2019 Mar 23, 2020	SELL	$78.51 - $87.4 $394,355 - $439,010	-5,023 Reduced 15.88%	26,612 $2.31 Million
Q3 2019 Mar 23, 2020	SELL	$81.84 - $88.74 $785,664 - $851,904	-9,600 Reduced 23.28%	31,635 $0
Q1 2019 Dec 09, 2019	SELL	$66.22 - $80.06 $35,030 - $42,351	-529 Reduced 1.27%	41,235 $3.3 Million
Q3 2018 Dec 09, 2019	BUY	$60.81 - $73.36 $30,465 - $36,753	501 Added 1.21%	41,764 $3.06 Million
Q2 2018 Oct 03, 2018	SELL	$57.57 - $63.54 $15,831 - $17,473	-275 Reduced 0.66%	41,263 $2.52 Million
Q1 2018 Oct 03, 2018	SELL	$56.27 - $63.62 $8,159 - $9,224	-145 Reduced 0.35%	41,538 $2.49 Million
Q4 2017 Jan 12, 2018	SELL	$53.68 - $57.47 $606,584 - $649,411	-11,300 Reduced 21.33%	41,683 $2.38 Million
Q3 2017 Jan 12, 2018	BUY	$48.06 - $53.64 $7,209 - $8,046	150 Added 0.28%	52,983 $2.83 Million
Q2 2017 Jan 22, 2018	BUY	N/A	52,833	52,833 $2.57 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

News

Stay updated on Chelsea Counsel CO with notifications on news.

Account

Chelsea Counsel CO Abbott Laboratories Transaction History